Amaia Esquisabel - Concepedia

Author

Amaia Esquisabel

University of the Basque Country ORCID

Also Known As

A Esquisabel, A. Esquisabel, A. Esquisabelr, Amaia Esquisabel

Publications

877

Citations

H-Index

Concepts

All Affiliations

University of the Basque Country Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine Universitat de Barcelona Consejo Superior de Investigaciones Científicas Fundación Canaria de Investigación Sanitaria

About

Amaia Esquisabel is an author at University of the Basque Country specializing in medicine, microbiology, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	275
2	Engineering	4	4	192
3	Biomedical Engineering	2	2	108
4	Immunology	2	2	135
5	Biomolecular Engineering	1	1	62

Amaia Esquisabel

Publications

693

Citations

H-Index

Page 1

	Year	Citations
Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres M. Igartua, Rosa Marı́a Hernández, Amaia Esquisabel, Journal of Controlled Release NanomedicineMucosal VaccinationEnhanced Immune ResponseImmunologyTherapeutic Vaccine	1998	105
Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis María Moreno-Sastre, Marta Pastor, Amaia Esquisabel, International Journal of Pharmaceutics NanomedicineEngineeringPulmonary DeliveryNano-drug DeliveryMicrobiology	2015	78
Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients Eulàlia Sans-Serramitjana, Ester Fusté, Blanca Martínez‐Garriga, Journal of Cystic Fibrosis Nanoencapsulated Colistin SulfateNanobiotechnologyCystic Fibrosis PatientsPseudomonas AeruginosaMicrobiology	2015	72
Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis Marta Pastor, María Moreno-Sastre, Amaia Esquisabel, International Journal of Pharmaceutics Lipid NanocarriersNanomedicineLipid PreparationEngineeringNano-drug Delivery	2014	62
Influence of Formulation Variables on the In-Vitro Release of Albumin from Biodegradable Microparticulate Systems M. Igartua, Rosa Marı́a Hernández, Amaia Esquisabel, Journal of Microencapsulation	1997	54
Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials Israel Molina, Fernando Salvador, Adrián Sánchez‐Montalvá, Antimicrobial Agents and Chemotherapy	2017	49
iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation Aarne Fleischer, Sara Vallejo‐Díez, José María Martín‐Fernández, Molecular Therapy — Methods & Clinical Development	2020	46
A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae Gemma Año, Amaia Esquisabel, Marta Pastor, Vaccine VaccinationMucosal VaccinationVaccine DevelopmentMicrobiologyInfection Control	2011	43
Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease Teresa Vinuesa, Rocío Herráez, Laura Feliz Oliver, American Journal of Tropical Medicine and Hygiene	2017	43
An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles M. Pastor, Amaia Esquisabel, A Talavera, International Journal of Pharmaceutics VaccinationMucosal VaccinationImmunologyGastro-resistant MicroparticlesMicrobiology	2013	30

Page 1